Listen to a brief discussion on Rheumatoid Arthritis and the myths behind it.
Dr. Ramchandani discusses arthritis and the different types of arthritis. He goes into the basic details about different arthritis types and why things happen. Don’t miss episode 19 on Rheumatoid […]
CEO and Founder of Neurovations and Eric J. Grigsby, MD, MBA and Peter Staats, MD, MBA met recently for a conversation exploring Neuromodulation for the COVID-19 Cytokine Storm.
The Physiatry Podcast 17- Discussion with ICU Fellow from the Front Lines, Dr. Priyanka Teckchandani
The Physiatry Podcast, episode 17 is a discussion with Dr. Priyanka Teckchandani from the frontlines of the COVID-19 pandemic…… And a discussion about if you should wear a mask while […]
Dr. Ruben Kalra recently joined the founder and CEO of Neurovations, Dr. Eric Grigsby to share timely and relevant tips on how to stay afloat as an independent medical practice […]
Brief Updates on Topics for Pain Management
The Neurovations family of businesses is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone and applying the relevant accessibility standards. […]
CEO and Founder of Neurovations Honored as Patient Champion NAPA, Calif., October 16, 2019 (Newswire.com) – Dr. Eric Grigsby was awarded the Visionary Leadership Award at the 6th Annual Business of […]
In the world of neurotech research, Case Western Reserve University serves as our inherent “Six Degrees of Kevin Bacon.” In fact, at the 2018 NIC Conference in Minneapolis, our happy […]
In the past, we’ve seen things like bioelectronic medicine defined as the nexus between the molecular target, the signal or neural pathway, and the device – or even more broadly […]
The Napa Pain Institute welcomes Dr. David C. Miller, triple Board Certified in the field of Pain Management and Anesthesiology.
Dr. Czura believes that Neuromodulation: The Science (NTS) builds a deeper understanding of the molecular and cellular mechanisms of neuromodulation, both in nerves and in target organs, is essential to develop more specific and more effective technologies for a broader range of indications.